Abstract

There have been considerable recent advances in understanding the genetic architecture of Tourette Syndrome (TS) as well as its underlying neurocircuitry. However, the mechanisms by which genetic variation that increases risk for TS—and its main symptom dimensions—influence relevant brain regions are poorly understood. Here we undertook a genome-wide investigation of the overlap between TS genetic risk and genetic influences on the volume of specific subcortical brain structures that have been implicated in TS. We obtained summary statistics for the most recent TS genome-wide association study (GWAS) from the TS Psychiatric Genomics Consortium Working Group (4644 cases and 8695 controls) and GWAS of subcortical volumes from the ENIGMA consortium (30,717 individuals). We also undertook analyses using GWAS summary statistics of key symptom factors in TS, namely social disinhibition and symmetry behaviour. SNP effect concordance analysis (SECA) was used to examine genetic pleiotropy—the same SNP affecting two traits—and concordance—the agreement in single nucelotide polymorphism (SNP) effect directions across these two traits. In addition, a conditional false discovery rate (FDR) analysis was performed, conditioning the TS risk variants on each of the seven subcortical and the intracranial brain volume GWAS. Linkage disequilibrium score regression (LDSR) was used as validation of the SECA method. SECA revealed significant pleiotropy between TS and putamen (p = 2 × 10−4) and caudate (p = 4 × 10−4) volumes, independent of direction of effect, and significant concordance between TS and lower thalamic volume (p = 1 × 10−3). LDSR lent additional support for the association between TS and thalamus volume (p= 5.85 × 10−2). Furthermore, SECA revealed significant evidence of concordance between the social disinhibition symptom dimension and lower thalamus volume (p = 1 × 10−3), as well as concordance between symmetry behaviour and greater putamen volume (p = 7 × 10−4). Conditional FDR analysis further revealed novel variants significantly associated with TS (p < 8 × 10−7) when conditioning on intracranial (rs2708146, q = 0.046; and rs72853320, q = 0.035) and hippocampal (rs1922786, q = 0.001) volumes, respectively. These data indicate concordance for genetic variation involved in disorder risk and subcortical brain volumes in TS. Further work with larger samples is needed to fully delineate the genetic architecture of these disorders and their underlying neurocircuitry.

Details

Title
Concordance of genetic variation that increases risk for Tourette Syndrome and that influences its underlying neurocircuitry
Author
Mufford, Mary 1   VIAFID ORCID Logo  ; Cheung, Josh 2 ; Jahanshad Neda 2 ; van der Merwe Celia 1 ; Ding, Linda 2 ; Groenewold Nynke 3 ; Nastassja, Koen 4 ; Chimusa, Emile R 1   VIAFID ORCID Logo  ; Dalvie Shareefa 4 ; Ramesar Raj 1 ; Knowles, James A 5 ; Lochner, Christine 6 ; Hibar, Derrek P 2 ; Paschou Peristera 7 ; van den Heuvel Odile A 8 ; Medland, Sarah E 9 ; Scharf, Jeremiah M 10 ; Mathews, Carol A 11 ; Thompson, Paul M 2 ; Stein, Dan J 4 

 University of Cape Town, Human Genetics Research Unit, Division of Human Genetics, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, Cape Town, South Africa (GRID:grid.7836.a) (ISNI:0000 0004 1937 1151) 
 Keck School of Medicine of the University of Southern California, Imaging Genetics Center, Mark and Mary Stevens Neuroimaging & Informatics Institute, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853) 
 University of Cape Town, Department of Psychiatry and MRC Unit on Risk & Resilience, Cape Town, South Africa (GRID:grid.7836.a) (ISNI:0000 0004 1937 1151) 
 University of Cape Town, Department of Psychiatry and MRC Unit on Risk & Resilience, Cape Town, South Africa (GRID:grid.7836.a) (ISNI:0000 0004 1937 1151); Groote Schuur Hospital and Neuroscience Institute, Cape Town, South Africa (GRID:grid.413335.3) (ISNI:0000 0004 0635 1506) 
 University of Southern California, Department of Psychiatry and the Behavioural Sciences, Zilkha Neurogenetic Institute, Keck School of Medicine, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853) 
 University of Stellenbosch, Department of Psychiatry, Stellenbosch, South Africa (GRID:grid.11956.3a) (ISNI:0000 0001 2214 904X) 
 Purdue University, Department of Biological Sciences, West Lafayette, USA (GRID:grid.169077.e) (ISNI:0000 0004 1937 2197) 
 VU University Medical Center, Amsterdam Neuroscience, Department of Psychiatry, Department of Anatomy & Neurosciences, Amsterdam, Netherlands (GRID:grid.484519.5) 
 QIMR Berghofer Medical Research Institute, Brisbane, Australia (GRID:grid.1049.c) (ISNI:0000 0001 2294 1395) 
10  Harvard Medical School, Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Massachusetts General Hospital, Department of Psychiatry, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924); Massachusetts General Hospital, Department of Neurology, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924) 
11  Genetics Institute, University of Florida, Department of Psychiatry, Gainesville, USA (GRID:grid.15276.37) (ISNI:0000 0004 1936 8091) 
Publication year
2019
Publication date
Dec 2019
Publisher
Nature Publishing Group
e-ISSN
21583188
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2195922488
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.